UA95028C2 - Композиция и способ лечения или предупреждения доброкачественной простатической гиперплазии и симптомов со стороны нижних - Google Patents

Композиция и способ лечения или предупреждения доброкачественной простатической гиперплазии и симптомов со стороны нижних

Info

Publication number
UA95028C2
UA95028C2 UAA201004418A UAA201004418A UA95028C2 UA 95028 C2 UA95028 C2 UA 95028C2 UA A201004418 A UAA201004418 A UA A201004418A UA A201004418 A UAA201004418 A UA A201004418A UA 95028 C2 UA95028 C2 UA 95028C2
Authority
UA
Ukraine
Prior art keywords
composition
urinary tract
benign prostatic
prostatic hyperplasia
lower urinary
Prior art date
Application number
UAA201004418A
Other languages
English (en)
Ukrainian (uk)
Inventor
Сеул-Минь Чой
Джу-Ми Ким
Кюн-Ку Кан
Бьнг-Ок Ан
Му-Хи Ю
Original Assignee
Донг-А Фарм. Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Донг-А Фарм. Ко., Лтд. filed Critical Донг-А Фарм. Ко., Лтд.
Publication of UA95028C2 publication Critical patent/UA95028C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Изобретение касается композиции, содержащей уденафил и тамсулозин, или уденафил и силодозин, и способа лечения или предупреждения доброкачественной простатической гиперплазии (ВРН) и симптомов со стороны нижних мочевых путей (LUTS) без проявления побочного эффекта кардинальной релаксацией гладких мышц в простате и мочевом пузыре.
UAA201004418A 2007-10-02 2008-09-24 Композиция и способ лечения или предупреждения доброкачественной простатической гиперплазии и симптомов со стороны нижних UA95028C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20070099016 2007-10-02

Publications (1)

Publication Number Publication Date
UA95028C2 true UA95028C2 (ru) 2011-06-25

Family

ID=40760274

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201004418A UA95028C2 (ru) 2007-10-02 2008-09-24 Композиция и способ лечения или предупреждения доброкачественной простатической гиперплазии и симптомов со стороны нижних

Country Status (4)

Country Link
KR (1) KR100920125B1 (ru)
SA (1) SA08290696B1 (ru)
UA (1) UA95028C2 (ru)
ZA (1) ZA201002470B (ru)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100353014B1 (ko) * 1998-11-11 2002-09-18 동아제약 주식회사 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물

Also Published As

Publication number Publication date
ZA201002470B (en) 2011-06-29
KR100920125B1 (ko) 2009-10-01
KR20090034266A (ko) 2009-04-07
SA08290696B1 (ar) 2013-04-20

Similar Documents

Publication Publication Date Title
WO2008030505A3 (en) Methods and compositions for the treatment of antibody mediated neuropathies
TW200738263A (en) ANG2 and VEGF inhibitor combinations
WO2008137867A3 (en) Compositions comprising mir34 therapeutic agents for treating cancer
WO2011037643A3 (en) Compositions and methods for detecting and treating prostate carcinoma
MX2010004502A (es) Metodos para tratar trastornos neurologicos urogenitales usando toxinas clostridiales modificadas.
MX2008011633A (es) Aminoquinolonas como inhibidores de gsk-3.
WO2008122049A3 (en) Methods and compositions for reduction of side effects of therapeutic treatments
NZ587057A (en) Method of treating prostate cancer with the gnrh antagonist degarelix
MX2009013725A (es) Composiciones de fragmentos de tejido para el tratamiento de la incontinencia.
WO2010024897A3 (en) Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer
WO2010059004A3 (ko) 스네일-p53 간의 결합을 저해하는 화합물 및 이를 유효성분으로 함유하는 암질환 치료제
BRPI0506970A (pt) derivados de alfa-aminoamida úteis no tratamento de distúrbios do trato urinário inferior
SG166106A1 (en) Pde inhibitors and combinations thereof for the treatment of urological disorders
WO2010014595A3 (en) Methods and compositions for delivering therapeutic agents in the treatment of b-cell related disorders
WO2010039461A3 (en) Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes
HK1162502A1 (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors gsk-3
WO2010097788A3 (en) Visfatin therapeutic agents for the treatment of acne and other conditions
WO2009009034A3 (en) Methods and compositions useful in the treatment of mucositis
WO2007130501A3 (en) Combination therapy for treatment of cancer
EP2083840A4 (en) IMPROVED TREATMENT FOR BENEFICIAL PROSTATE HYPERPLASIA
HK1102626A1 (en) Compositions and methods for the treatment and prevention of hyperproliferative diseases
WO2007134132A8 (en) Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors
WO2007136857A3 (en) Hox compositions and methods
MX2010003193A (es) Composicion y metodo para el tratamiento o prevencion de hiperplasia prostatica benigna y sintomas del tracto urinario inferior.
MX2009008073A (es) Inhibidores de epoxido hidrolasa solubles para el tratamiento de sindrome metabolico y trastornos relacionados.